Evidence map›Paper›PMID 35603277›Full record

ArticleCommunications medicine2022

Development and preliminary validation of a machine learning system for thyroid dysfunction diagnosis based on routine laboratory tests.

Min Hu, Chikashi Asami, Hiroshi Iwakura, Yasuyo Nakajima, Ryousuke Sema, Tsuyoshi Kikuchi, Tsuyoshi Miyata, Koji Sakamaki, Takumi Kudo, Masanobu Yamada and 2 more

Abstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Development and Validation of Machine-Learning-Based Prediction Models for Thyroid Diseases During Pregnancy.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Min Hu *AI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.
Chikashi Asami *AI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.
Hiroshi IwakuraFirst Department of Internal Medicine, Wakayama Medical University Hospital, Wakayama, Japan.ORCID 0000-0001-8033-0736
Yasuyo NakajimaDepartment of Internal Medicine, Gunma University Hospital, Maebashi, Gunma Japan.
Ryousuke SemaAI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.
Tsuyoshi KikuchiAI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.
Tsuyoshi MiyataAI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.
Koji SakamakiHealth Control Center, Hidaka Hospital, Takasaki, Gunma Japan.
Takumi KudoPresent Address: Department of Internal Medicine, Kuma Hospital, Kobe, Hyogo Japan.
Masanobu YamadaDepartment of Internal Medicine, Gunma University Hospital, Maebashi, Gunma Japan.
Takashi AkamizuFirst Department of Internal Medicine, Wakayama Medical University Hospital, Wakayama, Japan.ORCID 0000-0003-4960-8271
Yasubumi SakakibaraAI Strategy Team, Cosmic Corporation Co., Ltd, Tokyo, Japan.ORCID 0000-0002-6932-3452

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Approximately 2.4 million patients in Japan would benefit from treatment for thyroid disease, including Graves' disease and Hashimoto's disease. However, only 450,000 of them are receiving treatment, and many patients with thyroid dysfunction remain largely overlooked. In this retrospective study, we aimed to develop and conduct preliminary testing on a machine learning method for screening patients with hyperthyroidism and hypothyroidism who would benefit from prompt medical treatment. Methods: We collected electronic medical records and medical checkup data from four hospitals in Japan. We applied four machine learning algorithms to construct classification models to distinguish patients with hyperthyroidism and hypothyroidism from control subjects using routine laboratory tests. Performance evaluation metrics such as sensitivity, specificity, and the area under receiver operating characteristic (AUROC) were obtained. Techniques such as feature importance were further applied to understand the contribution of each feature to the machine learning output. Results: The results of cross-validation and external evaluation indicated that we achieved high classification accuracies (AUROC = 93.8% for hyperthyroidism model and AUROC = 90.9% for hypothyroidism model). Serum creatinine (S-Cr), mean corpuscular volume (MCV), and total cholesterol were the three features that were most strongly correlated with the hyperthyroidism model, and S-Cr, lactic acid dehydrogenase (LDH), and total cholesterol were correlated with the hypothyroidism model. Conclusions: We demonstrated the potential of machine learning approaches for diagnosing the presence of thyroid dysfunction from routine laboratory tests. Further validation, including prospective clinical studies, is necessary prior to application of our method in the clinic.

Indexed as

Diagnostic markersThyroid diseases

Identifiers

PMID35603277
PMCPMC9053267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.